CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of...

Ways B2B Ecommerce is Transforming Life Science

Ways B2B Ecommerce is Transforming...

Partnering with a 3PL to Address Complex Regulatory and Compliance Challenges in Life Sciences

Partnering with a 3PL to Address...

3PL and Distribution: Key Trends and Challenges to Know

3PL and Distribution: Key Trends and...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of...

Ways B2B Ecommerce is Transforming Life Science

Ways B2B Ecommerce is Transforming...

Partnering with a 3PL to Address Complex Regulatory and Compliance Challenges in Life Sciences

Partnering with a 3PL to Address...

3PL and Distribution: Key Trends and Challenges to Know

3PL and Distribution: Key Trends and...

Multiomic Preclinical Models to Define the Mechanism of Action

Multiomic Preclinical Models to...

Developing Patient-Centric Precision Oncology Therapies: Begin With The End In Mind

Developing Patient-Centric Precision...

What the New EMA Draft

What the New EMA Draft "Guideline on...

Pharmaceutical Tablet Coating - Past, Present and Future

Pharmaceutical Tablet Coating - Past,...

How Digital Transformation Can Improve Pharma Supply Chain Resilience

Life Sciences Review | Friday, March 25, 2022
Tweet

Transitioning toward a digital supply chain allows pharmaceutical businesses to cooperate with supply networks and efficiently produce value.


Fremont, CA: Since 2020, the development and dissemination of COVID-19 vaccinations have spotlighted the pharmaceutical supply chain. Companies have found new methods to collaborate to supply millions of doses, formed new alliances, and overcome new distribution hurdles.


Despite the vaccination deployment, the pharmaceutical sector has faced significant hurdles and changes, including greater regulation, mergers and acquisitions, and changing customer demands in a competitive industry.


As a result, the pharmaceutical sector is focusing on strengthening supply chain resilience while preserving lean flexibility to pivot in shifting market conditions.


To fulfill these objectives, pharmaceutical businesses must transition their supply chains from segregated networks to a more integrated and collaborative architecture that delivers centralized, real-time data transparency to link partners and allow operational efficiency. However, supply constraints add a new dimension of immediacy to this dilemma.


Here are three supply chain concerns where digital transformation may help enhance resilience:


 


• GxP-compliant solutions improve data transparency and quality management


Digital supply chain platforms that adhere to GxP rules for manufacturing processes can assist pharmaceutical manufacturers in more effectively collecting and tracking supply chain data to maintain consistent quality in their raw material and finished goods. A more precise track and trace reduce the likelihood of an expensive recall.


• Collaboration between pharmaceutical corporations and contract manufacturers is lacking


With that complexity, having a single, AI-powered platform to store and analyze data in real-time can produce savings while avoiding interruptions caused by forecast or capacity planning concerns.


• R&D and new product development delays and barriers


Due to supply constraints and the reallocation of medical resources to accelerate the response to COVID-19, clinical studies and critical research and development in the pharmaceutical supply chain got delayed.


A strong supply ecosystem is required in the pharmaceutical sector to support financing, infrastructure, and cooperation for the research and development of new products. In addition, supplier chain and procurement organizations can help make research and approval procedures more streamlined and efficient by bridging gaps in the supply network and centralizing data.


Weekly Brief

loading
Top 10 Life Science 3PL Services Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/how-digital-transformation-can-improve-pharma-supply-chain-resilience-nwid-752.html